Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology/Urology
Clinical Trials: Kidney Cancer
A listing of clinical trials currently looking for volunteers to enroll in Kidney Cancer studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Various Cities : Research Center
Tuberous Sclerosis (Kidney Lesions) Study - M2302
Arizona
Various Cities : Research Center
Tuberous Sclerosis (Kidney Lesions) Study - M2302
Arkansas
Various Cities : Research Center Updated
Kidney Cancer (Clear Cell Carcinoma) Study - L2201
California
Duarte : City of Hope Updated
A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients with CD70- Positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Duarte : City of Hope Updated
A Phase II Study of Pazopanib in VEGF-TKI Refractory Metastatic Renal Cell Carcinoma (MRCC)
Duarte : City of Hope Updated
A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging of Renal Cortical Tumors
Duarte : City of Hope Updated
Development of a Blood Test of Anti-IMP3 Autoantibody for the Detection of Renal Cell Carcinoma with Metastasis and Metastatic Potential
Duarte : City of Hope Updated New
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Duarte : City of Hope Updated New
Phase I/II Study of Dalteparin, a Low Molecular Weight Heparin (LMWH), in Combination with Sunitinib (SU11248), an Oral, Selective Multi-Targeted Tyrosine Kinase Inhibitor, as First Line Treatment, in Patients with Metastatic Renal Cell Carcinoma
Duarte : City of Hope Updated
SWOG S0931: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Various Cities : Research Center Updated
Kidney Cancer (Clear Cell Carcinoma) Study - L2201
View More »
Encinitas : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Colorado
Denver : The Urology Center of Colorado
Phase II, open-label study evaluating DN24-02 as adjuvant therapy in subjects with high risk HER2+ urothelial carcinoma.
Connecticut
New Haven : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Florida
Various Cities : Research Center
Tuberous Sclerosis (Kidney Lesions) Study - M2302
Georgia
Savannah : Memorial Health University Medical Center
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor AREN 0534
Savannah : Memorial Health University Medical Center
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor COG-AREN0533
Savannah : Memorial Health University Medical Center
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors COG AREN0321
Savannah : Memorial Health University Medical Center
Study of Kidney Tumors in Young Patients COG AREN03B2
Savannah : Memorial Health University Medical Center
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery ECOG E2805
Savannah : Memorial Health University Medical Center
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor COG AREN0532
Maryland
Bethesda : Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
Salisbury : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Massachusetts
Various Cities : Research Center
Tuberous Sclerosis (Kidney Lesions) Study - M2302
View More »
Boston : Beth Israel Deaconess Medical Center
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Boston : Beth Israel Deaconess Medical Center
Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Michigan
Various Cities : Research Center Updated
Kidney Cancer (Clear Cell Carcinoma) Study - L2201
Minnesota
Various Cities : Research Center
Tuberous Sclerosis (Kidney Lesions) Study - M2302
Nebraska
Omaha : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Nevada
Various Cities : Research Center Updated
Kidney Cancer (Clear Cell Carcinoma) Study - L2201
New Jersey
New Brunswick : Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melanoma Treated on Clinical Trial NCI-06-C-0200
New York
Bronx : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
New York : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
North Carolina
Durham : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Goldsboro : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Ohio
Various Cities : Research Center
Tuberous Sclerosis (Kidney Lesions) Study - M2302
Pennsylvania
Various Cities : Research Center Updated
Kidney Cancer (Clear Cell Carcinoma) Study - L2201
Tennessee
Nashville : Vanderbilt Univeristy Medical Center
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Texas
Houston : S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Carcinoma Of The Kidney
Various Cities : Research Center Updated
Kidney Cancer (Clear Cell Carcinoma) Study - L2201
View More »
Houston : UT MD Anderson Cancer Center
Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Houston : UT MD Anderson Cancer Center
Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)
Houston : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Houston : UT MD Anderson Cancer Center
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)
Washington
Various Cities : Research Center Updated
Kidney Cancer (Clear Cell Carcinoma) Study - L2201
West Virginia
Morgantown : West Virginia University - Clinical Trials Research Unit
ECOG1808-A Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features
Canada
Québec : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Québec : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
France
Limoges Cedex : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Montpellier Cedex 5 : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Villejuif cedex : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Italy
Bologna : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Firenze (FI) : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Milano : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Padova : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Roma : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Poland
Warszawa : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium